Advertisement
Advertisement
CAI
Caris Life Sciences, Inc. Common Stock
35.87
USDSponsored
+0.41
+1.17%
Oct 29, 11:18 UTC -4
Open
Caris Life Sciences, Inc. Common Stock (CAI) Earnings
CAI Earnings Reports
Positive Surprise Ratio
CAI beat 3 of 5 last estimates.
60%
Next Report
Next Week
Date of Next Report
Nov 04, 2026
Estimate for Q3 26 (Revenue/ EPS)
$257.92M
/$0.03
Implied change from Q2 26 (Revenue/ EPS)
-2.20%
/--
Implied change from Q3 25 (Revenue/ EPS)
+18.95%
/-62.50%
Caris Life Sciences, Inc. Common Stock earnings per share and revenue
On Aug 05, 2026, CAI reported earnings of 0.00 USD per share (EPS) for Q2 26, missing the estimate of 0.01 USD, resulting in a -100.00% surprise. Revenue reached 263.71 million, compared to an expected 240.51 million, with a 9.65% difference. The market reacted with a +21.58% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 8 analysts forecast an EPS of 0.03 USD, with revenue projected to reach 257.92 million USD, implying an -- of --% EPS, and decrease of -2.20% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Danaher Corporation
Report Date
Oct 21, 2026 For Q3 26
Estimate
$1.93
Actual
$2.11
Surprise
+8.99%
HCA Healthcare, Inc.
Report Date
Oct 27, 2026 For Q3 26
Estimate
$6.72
Actual
$7.22
Surprise
+7.29%
Elevance Health, Inc.
Report Date
Oct 21, 2026 For Q3 26
Estimate
$4.72
Actual
$6.99
Surprise
+47.81%
Labcorp Holdings Inc.
Report Date
Oct 28, 2026 For Q3 26
Estimate
$4.79
Actual
$4.78
Surprise
-0.31%
Medpace Holdings, Inc. Common Stock
Report Date
Oct 21, 2026 For Q3 26
Estimate
$4.52
Actual
$4.84
Surprise
+6.98%
Icon Plc
Report Date
Oct 27, 2026 For Q3 26
Estimate
$2.65
Actual
$2.66
Surprise
+0.27%
Avantor, Inc.
Report Date
Oct 28, 2026 For Q3 26
Estimate
$0.21
Actual
$0.22
Surprise
+3.92%
Bausch + Lomb Corporation
Report Date
Oct 28, 2026 For Q3 26
Estimate
$0.22
Actual
$0.34
Surprise
+53.43%
Pediatrix Medical Group, Inc.
Report Date
Oct 29, 2026 For Q3 26
Estimate
$0.66
Actual
$0.72
Surprise
+7.61%
Establishment Labs Holdings Inc.
Report Date
Oct 29, 2026 For Q3 26
Estimate
-$0.26
Actual
-$0.35
Surprise
-33.69%
FAQ
What were Caris Life Sciences, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Caris Life Sciences, Inc. Common Stock reported EPS of $0.00, missing estimates by -100%, and revenue of $263.71M, 9.65% above expectations.
How did the market react to Caris Life Sciences, Inc. Common Stock's Q2 2026 earnings?
The stock price moved up 21.58%, changed from $16.45 before the earnings release to $20.00 the day after.
When is Caris Life Sciences, Inc. Common Stock expected to report next?
The next earning report is scheduled for Nov 04, 2026.
What are the forecasts for Caris Life Sciences, Inc. Common Stock's next earnings report?
Based on 8
analysts, Caris Life Sciences, Inc. Common Stock is expected to report EPS of $0.03 and revenue of $257.92M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.